Sensidose is a pharmaceutical company. The company has developed a system for individualized dosing of tablets, a medical treatment using a dosing device pre-programmed for the patient. The company's product portfolio includes a number of brands and drugs intended for the treatment of, for example, Parkinson's. The main operations are in the Nordic region.

Quotes for Sensidose Aktiebolag

Right Now

+/-
%
0,00%
Latest
High
Low
Volume
0
Turnover (SEK)
0
Market Value (MSEK)
41,9
Time (Latest trade)

Board

CEO

  • Jack Spira

Chairperson of the Board

  • Per Nilsson

Board

  • Åsa Kornfeld
  • Jack Spira
  • Lasse Tenerz
  • Sten-Magnus Aquilonius

Largest Owners

Name Capital % Votes % Date
BWG Invest Sàrl (William Gunnarsson) 11,61 11,61 2022-05-12
Per Vasilis 9,52 9,52 2022-06-28
Christer Nyström 8,09 8,09 2022-06-28
Lars-Åke Adolfsson 7,88 7,88 2022-06-28
Jungfrutomten Värdeinvest Aktiebolag 6,82 6,82 2022-06-28
Gerhard Dal 4,60 4,60 2022-06-28
Lars Tenerz 4,26 4,26 2022-09-29
Håkan Englund 2,91 2,91 2022-06-28
Anders Lundmark 2,76 2,76 2022-06-28
Per Nilsson 2,46 2,46 2022-06-07
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2022-11-10 Delårsrapport 2022-Q3

  • 2023-02-16 Bokslutskommuniké 2022